New fertility drug aims to boost IVF live birth rates

NCT ID NCT07216742

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 3 trial tests whether a daily injection of human menopausal gonadotropin (hMG) can help women with infertility develop more eggs and achieve a live birth during IVF. About 659 women aged 18-42 will receive either the hormone or a placebo. The main goal is to see if the treatment leads to more live births after transferring a single, genetically normal embryo.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
human menopausal gonadotropin (hMG) injection
What this could lead to
If successful, this could offer a more effective option for stimulating egg growth during IVF, potentially increasing the chance of a live birth.
What could go wrong
This is a phase 3 trial, but results may not apply to all infertility cases. The placebo group may also show success, and individual responses to hormones vary. Risks include ovarian hyperstimulation and multiple pregnancy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY (IVF PATIENTS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Boston IVF

    RECRUITING

    Waltham, Massachusetts, 02451, United States

    Contact Email: •••••@•••••

  • CARE Fertility

    RECRUITING

    Bedford, Texas, 76022, United States

  • Carolina Conceptions

    RECRUITING

    Raleigh, North Carolina, 27607, United States

    Contact Email: •••••@•••••

  • Center for Reproductive Medicine

    RECRUITING

    Winter Park, Florida, 32789, United States

  • Fertility Centers of Illinois

    RECRUITING

    Chicago, Illinois, 60610, United States

    Contact Email: •••••@•••••

  • Fertility Institute of Hawaii

    RECRUITING

    Honolulu, Hawaii, 96814, United States

  • HRC Fertility

    RECRUITING

    Encino, California, 91436, United States

  • IVF Florida Reproductive Associates

    RECRUITING

    Margate, Florida, 33036, United States

  • Illume Fertility

    RECRUITING

    Norwalk, Connecticut, 06851, United States

  • Main Line Fertility

    RECRUITING

    Bryn Mawr, Pennsylvania, 19010, United States

    Contact Email: •••••@•••••

  • Pinnacle Fertility - Oregon

    RECRUITING

    Portland, Oregon, 97205, United States

  • Reach Fertility

    RECRUITING

    Charlotte, North Carolina, 28207, United States

    Contact Email: •••••@•••••

  • Reproductive Associates of Delaware CCRM

    NOT_YET_RECRUITING

    Newark, Delaware, 19713, United States

  • Reproductive Biology Associates (RBA)

    RECRUITING

    Atlanta, Georgia, 30342, United States

  • Shady Grove Fertility - Rockville

    RECRUITING

    Rockville, Maryland, 20850, United States

    Contact Email: •••••@•••••

  • Shady Grove Houston

    RECRUITING

    Webster, Texas, 77598, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.